# Hemodynamic and Pharmacokinetic Analysis of Oxymetazoline Absorption

> **NCT02062996** · PHASE2 · WITHDRAWN · sponsor: **Richard Cartabuke**

## Conditions studied

- Dental Anesthesia
- Nasal Surgical Procedures
- Intranasal Drug Administration

## Interventions

- **DRUG:** Oxymetazoline

## Key facts

- **NCT ID:** NCT02062996
- **Lead sponsor:** Richard Cartabuke
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-06
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Could not receive FDA approval for IND
- **Last updated:** 2015-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02062996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02062996, "Hemodynamic and Pharmacokinetic Analysis of Oxymetazoline Absorption". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT02062996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*